U.S. to Allow Medicaid to Pay for Drug Treatment in Prisons

WEDNESDAY, Feb. 22, 2023 (HealthDay News) -- Soon, the federal government will allow states to use Medicaid funds to treat prisoners for drug addiction and mental health services.

In an announcement made during a visit to the Camden County Jail in New Jersey on Tuesday, Rahul Gupta, M.D., director of the White House Office of National Drug Control Policy, said states are being encouraged to submit proposals for how they would like to use that money, the Associated Press reported. But the government will require that mental health and drug treatment be offered as part of allowing Medicaid funds in jails and prisons.

Gupta said the U.S. Centers for Medicare & Medicaid Services will release full guidance on the funds this spring, the AP reported. By summer, all federal prisons will offer medications to treat substance use disorder, he added.

Allowing drug treatment in prisons and jails could help keep people alive, advocates say. "We're really hopeful that this coverage will help people improve their health outcomes and avoid additional involvement in the criminal justice system," Gabrielle de la Gueronniere, vice president for health and justice policy at the Legal Action Center, told the AP.

A majority of incarcerated people are addicted to drugs. Former inmates are also more likely to die in the first few weeks after release than the average nonincarcerated person, because their tolerance to drugs decreases while incarcerated, the AP reported.

The significance of the change depends on the state. In New Jersey, where Gupta toured, 20 of the state's 21 counties already have medication-assisted treatment in jails, said State Human Services Commissioner Sarah Adelman. About one-fourth of inmates in the Camden County Jail receive medication treatment, the AP reported. There, the change will be in funding, which could also make a difference. An opioid addiction treatment called Sublocade has cost the Camden County Jail more than $528,000 since 2019 for 170 people. The shot is administered every four weeks. Alternatively, a similar drug offered as a pill cost about $664,000 for 3,100 people.

Associated Press Article